A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II)

Journal of the American College of Cardiology

Volumn 45, Issue 11, 2005, Pages 1775-1780

  Ross, Allan M ^a   Gibbons, Raymond J ^b   Stone, Gregg W ^c   Kloner, Robert A ^d   Alexander, R Wayne ^e,f  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b MAYO CLINIC   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HOSPITALIZATION; HUMAN; HYPOTENSION; MALE; MULTICENTER STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADENOSINE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY; VASODILATOR AGENTS;

EID: 20344394410     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.02.061     Document Type: Article

References (41)

1. R.A. Kloner, S.H. Rezkalla Cardiac protection during acute myocardial infarction where do we stand in 2004? J Am Coll Cardiol 44 2004 276 286
2. The European Myocardial Infarction Project Free Radicals (EMIP-FR) Group Effect of 48-hour intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy. A double-blind, placebo-controlled randomized trial Eur Heart J 21 2000 1537 1546
3. T.C. Wall, R.M. Califf, J. Blankenship Intravenous fluosol in the treatment of acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction 9 trial Circulation 90 1994 114 120
4. Collaborative Organization for Rheoth RX Evaluation (CORE) Investigators Effects of Rheoth Rx on mortality, morbidity, left ventricular function, and infarct size in patients with acute myocardial infarction Circulation 96 1997 192 201
5. K.W. Baran, M. Nguyen, G.R. McKendall Double-blind randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction Circulation 104 2001 2778 2783
6. D.P. Faxon, R.J. Gibbons, N.A. Chronos The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty the results of the HALT-MI study J Am Coll Cardiol 40 2002 1199 1204
7. K.W. Mahaffey, C.B. Granger, J.C. Nicolau COMPLY Investigators Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial Circulation 108 2003 1176 1183
8. K. Malmberg the DIGAMI Study Group Prospective randomized study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus BMJ 314 1997 1512 1515
9. R. Diaz, E.A. Paolasso, L.S. Piegas Metabolic modulation of acute myocardial infarction Circulation 98 1998 2227 2234
10. + exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA Circulation 101 2000 2902 2908
11. P. Theroux, B.R. Chaitman, N. Danchin Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial Circulation 102 2000 3032 3038
12. K.L. Woods, S. Fletcher, C. Roffe Intravenous magnesium sulfate in suspected acute myocardial infarction results of the second Leicester Intravenous Magnesium Intervention trial (LIMIT-2) Lancet 339 1992 1553 1558
13. P.M. Kaminski, K.G. Proctor Attenuation of no-reflow phenomenon, neutrophil activation, and reperfusion injury in intestinal microcirculation by topical adenosine Circ Res 65 1989 426 435
14. D.G. Babbitt, R. Virmani, M.B. Forman Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model Circulation 80 1989 1388 1399
15. J.D. Thornton, G.S. Liu, R.A. Olsson Intravenous pretreatment with A1-selective adenosine analogue protects the heart against infarction Circulation 85 1992 659 665
16. K.N. Garratt, D.R. Holmes Jr, V. Molina-Viamonte Intravenous adenosine and lidocaine in patients with acute myocardial infarction Am Heart J 136 1998 196 204
17. M. Marzilli, E. Orsini, P. Maraccini Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction Circulation 101 2000 2154 2159
18. K.W. Mahaffey, J.A. Puma, A. Barbagelata Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction. Results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial J Am Coll Cardiol 34 1999 1711 1720
19. M. Quintana, P. Hjemdahl, A. Solleri Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study Eur J Clin Pharmacol 59 2003 1 9
20. A.R. Assali, S. Sdringola, M. Ghani Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of "no-reflow" phenomenon Cathet Cardiovasc Interv 51 2000 27 31
21. M.A. Leesar, M. Stoddard, M. Ahmed Preconditioning of human myocardium with adenosine during coronary angioplasty Circulation 95 1997 2500 2507
22. R.M. Mentzer, V. Birjiniuk, S. Khuri Adenosine myocardial protection preliminary results of a phase II clinical trial Ann Surg 229 1999 643 649
23. M.K. O'Connor, R.J. Gibbons Quantitative myocardial SPECT for infarct sizing feasibility of a multicenter trial assessed by means of a cardiac phantom J Nucl Med 36 1995 1130 1136
24. T.F. Christian, R.S. Schwartz, R.J. Gibbons Determinants of infarct size in reperfusion therapy for acute myocardial infarction Circulation 86 1992 81 90
25. T.F. Christian, T. Behrenbeck, P.A. Pellikka Mismatch of left ventricular function and infarct size demonstrated by technetium-99m isonitrile imaging after reperfusion therapy for acute myocardial infarction identification of myocardial stunning and hyperkinesia J Am Coll Cardiol 16 1990 1632 1638
26. P. Chareonthaitawee, T.F. Christian, K. Hirose Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction J Am Coll Cardiology 25 1995 567 573
27. R. Medrano, R.W. Lowry, J.B. Young Assessment of myocardial viability with 99mTc sestamibi in patients undergoing cardiac transplantation Circulation 94 1996 1010 1017
28. H.A. Dakik, J.F. Howell, G.M. Lawrie Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery correlation with histopathology and postoperative improvement in cardiac function Circulation 96 1997 2892 2898
29. J.E. Udelson, P.S. Coleman, J. Metherall Predicting recovery of severe regional dysfunction comparison of resting scintigraphy with 201-T1 and 99m Tc-sestamibi Circulation 89 1994 2552 2561
30. A.F. Maes, M. Borgers, W. Flameng Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT J Am Coll Cardiol 29 1997 62 68
31. T.D. Miller, T.F. Christian, M.R. Hopfenspirger Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality Circulation 92 1995 334 341
32. R.J. Burns, R.J. Gibbons, Q. Yi The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis J Am Coll Cardiol 39 2002 30 36
33. A. Schomig, A. Kastrati, J. Dirschinger Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction study Investigators N Engl J Med 343 2000 385 391
34. A. Kastrati, J. Mehilli, J. Dirschinger Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction (STOPAMI-2) Study Investigators Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction a randomised trial Lancet 359 2002 920 925
35. E.D. Norton, E.K. Jackson, R. Virmani, M.B. Forman Effect of intravenous adenosine on myocardial reperfusion injury in a model with low myocardial collateral blood flow Am Heart J 122 1991 1283 1291
36. B. Olafsson, M.B. Forman, D.W. Puett Reduction of reperfusion injury in the canine preparation by intracoronary adenosine importance of the endothelium and the no-reflow phenomenon Circulation 76 1987 1135 1145
37. M.B. Forman, C.E. Velasco, E.K. Jackson Adenosine attenuates reperfusion injury following regional myocardial ischemia Cardiovasc Res 27 1993 9 17
38. ATP channels Circulation 89 1994 1226 1236
39. C.J. Pitarys, R. Virmani, H.D. Vildibill Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period Circulation 83 1991 237 247
40. J.P. Headrick, B. Hack, K.J. Ashton Acute adenosinergic cardioprotection in ischemic-reperfused hearts Am J Physiol Heart Circ Physiol 285 2003 H1797 H1818
41. K. Hata, P. Whittaker, R.A. Kloner Brief antecedent ischemia attenuates platelet mediated thrombus in damaged and stenotic canine coronary arteries role of adenosine Circulation 97 1998 692 702